Beta Drugs
0
4
+₹0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Oct 22Expected
Q4 2025
Q2 2026
Q3 2026
8.06
8.39
8.73
9.06
Expected EPS
N/A
Actual EPS
N/A
Financials
10.59%Profit Margin
Profitable4.72BRevenue
500MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SMBETA.NSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
Show More
CEO
Mr. Rahul Batra
Employees
455
Country
India
ISIN
INE351Y01019
Listings
0 Comments
Share your thoughts
FAQs
What is Beta Drugs stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange Beta Drugs stocks are traded under the ticker SMBETA.NSE.
When is the next Beta Drugs earnings date?▼
Beta Drugs is going to release the next earnings report on February 15, 2027.
What is Beta Drugs revenue for the last year?▼
Beta Drugs revenue for the last year amounts to 4.72B INR.
What is Beta Drugs net income for the last year?▼
SMBETA.NSE net income for the last year is 500M INR.
How many employees does Beta Drugs have?▼
As of November 2, 2026, the company has 455 employees.
In which sector is Beta Drugs located?▼
Beta Drugs operates in the Other sector.
When did Beta Drugs complete a stock split?▼
The last stock split for Beta Drugs was on March 26, 2025 with a ratio of 21:20.
Where is Beta Drugs headquartered?▼
Beta Drugs is headquartered in Panchkula, India.